Molgramostim biosimilar - Amega BiotechAlternative Names: recombinant GM-CSF - Amega Biotech
Latest Information Update: 15 Aug 2013
At a glance
- Originator Amega Biotech
- Class Chemoprotectants; Granulocyte-macrophage colony-stimulating factors; Recombinant proteins
- Mechanism of Action Granulocyte macrophage colony stimulating factor agonists; Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Leucopenia; Neutropenia
Most Recent Events
- 15 Aug 2013 Investigation in Neutropenia in Argentina (Parenteral)
- 15 Aug 2013 Investigation in Leucopenia in Argentina (Parenteral)